AzureCell is an award-winning biotech spin-off from the University of Geneva, advancing next-generation regenerative cell therapies for Parkinson’s disease and other neurodegenerative disorders. By integrating cutting-edge stem cell technologies with proprietary cell and genetic engineering platforms, we’re developing scalable, safe, and effective therapies that address the root cause of neurodegeneration.
Milestones/News
Videos and Presentations
Youtube